OPEN END TURBO OPTIONSSCHEIN SHORT - BRISTOL-MYERS SQUIBB | Real-time BOERSE MUENCHEN 06:26:04 2024-06-28 EDT | ||
| 1.123 EUR | +0.54% |
|
| Current month | -3.29% | ||
| 1 month | +0.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 1.123 | +0.54% |
| 24-06-27 | 1.117 | +8.66% |
| 24-06-26 | 1.028 | -3.93% |
| 24-06-25 | 1.07 | +1.33% |
| 24-06-24 | 1.056 | -6.30% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 06:26 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GG6NL9 |
| ISIN | DE000GG6NL94 |
| Date issued | 2024-04-08 |
| Strike | 53.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.2 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.252 € |
|---|---|
| Lowest since issue | 0.18 € |
| Spread | 0.01 € |
| Spread % | 0.88% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.51
USD
Average target price
53.19
USD
Spread / Average Target
+28.15%
- Stock Market
- Certificates
- Certificat
